Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
$1.16
-0.0600 (-4.92%)
At Close: May 10, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $0.90 $1.74 Friday, 10th May 2024 FGEN stock ended at $1.16. This is 4.92% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 8.04% from a day low at $1.12 to a day high of $1.21.
90 days $0.90 $2.93
52 weeks $0.335 $19.47

Historical FibroGen prices

Date Open High Low Close Volume
Nov 28, 2016 $23.40 $23.40 $22.60 $22.60 348 559
Nov 25, 2016 $23.20 $23.40 $22.60 $23.40 153 177
Nov 23, 2016 $21.10 $23.10 $20.85 $23.00 390 143
Nov 22, 2016 $23.25 $23.30 $21.33 $21.90 827 749
Nov 21, 2016 $23.25 $23.25 $22.52 $23.05 326 360
Nov 18, 2016 $22.65 $23.23 $22.30 $23.10 485 984
Nov 17, 2016 $22.05 $22.55 $21.80 $22.50 436 998
Nov 16, 2016 $22.45 $22.85 $21.77 $21.90 456 154
Nov 15, 2016 $21.60 $22.90 $21.30 $22.80 599 676
Nov 14, 2016 $22.50 $22.50 $21.54 $21.70 1 029 984
Nov 11, 2016 $21.05 $22.60 $20.50 $22.55 886 464
Nov 10, 2016 $20.15 $21.80 $19.75 $21.15 1 501 398
Nov 09, 2016 $17.50 $20.00 $17.20 $20.00 3 229 940
Nov 08, 2016 $16.25 $16.50 $15.70 $15.90 599 311
Nov 07, 2016 $16.50 $16.65 $16.03 $16.15 636 500
Nov 04, 2016 $15.70 $16.68 $15.70 $16.05 493 600
Nov 03, 2016 $16.45 $16.65 $15.60 $15.60 692 900
Nov 02, 2016 $16.60 $16.90 $16.40 $16.45 486 900
Nov 01, 2016 $16.65 $17.10 $16.55 $16.75 428 800
Oct 31, 2016 $16.70 $17.15 $16.40 $16.55 475 800
Oct 28, 2016 $16.30 $17.15 $16.05 $16.70 666 900
Oct 27, 2016 $17.15 $17.25 $16.33 $16.40 361 400
Oct 26, 2016 $16.85 $17.35 $16.56 $16.95 437 000
Oct 25, 2016 $17.00 $17.45 $16.70 $16.80 369 500
Oct 24, 2016 $17.45 $17.85 $17.00 $17.05 395 100
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Golden Star

Ticker Date Change Price
SXI May 08 2.97% $173.34
NVO May 08 1.37% $126.69
PAG May 07 1.42% $153.22
WMT May 06 1.02% $59.87
UNP May 06 3.42% $239.21
JPM May 06 3.53% $192.00
INGR May 03 4.94% $114.56
ASH May 03 2.28% $95.85
INVH May 03 1.13% $34.39
INTU May 03 0.483% $629.27
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT